|
| Characteristic | Value |
|
| Gender (male/female) | 39/137 |
| Age (year, median, range) | 46.00 (17–73) |
| Tumor diameter (cm, median, range) | 1.00 (0.20–5.00) |
| Duration of illness (day, median, range) | 60 (1–2920) |
| Node number (single/multi/NA) | 46/125/5 |
| Total thyroidectomy (radical operation) | |
| Bilateral CLND | 108 |
| Ipsilateral CLND | 13 |
| Bilateral CLND + bilateral cervical LND | 12 |
| Bilateral CLND + ipsilateral cervical LND | 35 |
| Ipsilateral CLND + ipsilateral cervical LND | 8 |
| Pathology | |
| Pathologic N (N0/N1/N2/N3) | 65/111/0/0 |
| Pathologic T (T1/T2/T3/T4/) | 132/16/28/0 |
| Pathology stage (I/II/III/IV) | 147/22/4/3 |
| Preoperative serum PTH (pg/ml, median, range) | 46.00 (16.52–234.9) |
| Preoperative serum Ca (mmol/l, median, range) | 2.35 (2.04–3.21) |
| POD1 serum PTH (pg/ml, median, range) | 18.00 (1.20–70.20) |
| POD1 serum Ca (mmol/l, median, range) | 2.00 (1.56–2.48) |
| Postoperative complications | |
| Convulsion | 57 |
| Numbness | 29 |
| None | 90 |
| Hypocalcemia (male/female) | |
| POD1 (n = 176) | 4/51 |
| POD3 (n = 101) | 8/51 |
| POD5 (n = 71) | 4/23 |
| POD7 (n = 60) | 2/11 |
| POD30 (n = 100) | 1/4 |
| POD90 (n = 74) | 0/4 |
| POD180 (n = 57) | 0/2 |
| POD365 (n = 35) | 0/1 |
|
